Mabascog, Baby Girl .
HRN: 25-13-30 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/17/2024
AMPICILLIN 250MG (VIAL)
05/17/2024
05/24/2024
IVT
150mg
Q12
Thinly MSAF
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes